HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings.

Abstract
Fibrosis has been reported in some patients with immune thrombocytopenia (ITP) treated with thrombopoietin receptor agonists (TPO-RA). However, fibrosis has also been reported in patients with various stages of ITP, who were TPO-RA treatment-naïve. In our study, we looked for fibrosis in bone marrow trephine biopsies taken at initial diagnosis from 32 adult patients with ITP. Ten of the 32 evaluated samples (31·25%) showed increased reticulin (Grade 1-2 on Bauermeister scale and Grade 0-1 on the European Consensus scale), which showed a positive correlation with ethnicity (0·3%) but did not correlate with disease severity, any clinical features or co-morbidities.
AuthorsHasan Rizvi, Tom Butler, Mariarita Calaminici, Indraraj U Doobaree, Raghava C Nandigam, Dimitri Bennett, Drew Provan, Adrian C Newland
JournalBritish journal of haematology (Br J Haematol) Vol. 169 Issue 4 Pg. 590-4 (May 2015) ISSN: 1365-2141 [Electronic] England
PMID25753327 (Publication Type: Clinical Trial, Journal Article, Multicenter Study)
Copyright© 2015 John Wiley & Sons Ltd.
Chemical References
  • Receptors, Thrombopoietin
  • MPL protein, human
Topics
  • Adolescent
  • Adult
  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Primary Myelofibrosis (complications, drug therapy, epidemiology, pathology)
  • Purpura, Thrombocytopenic, Idiopathic (complications, drug therapy, epidemiology, pathology)
  • Receptors, Thrombopoietin (agonists)
  • Registries
  • Retrospective Studies
  • Severity of Illness Index
  • United Kingdom

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: